Now, it’s worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 194% for ...
After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...
Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.
Fintel reports that on October 31, 2025, Wells Fargo maintained coverage of DexCom (NasdaqGS:DXCM) with a Overweight ...
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on third-quarter results that came in ahead of the consensus ...
Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback